Clinical Trial Update: The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe Sepsis

View source ↗

Summary

A clinical trial evaluating erythropoietin for microcirculatory alterations in ICU patients with severe sepsis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Sepsis, Shock | Status: TERMINATED